help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steinberger, A.
Right arrow Articles by Steinberger, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steinberger, A.
Right arrow Articles by Steinberger, E.

Endocrinology, Vol 111, 696-698, Copyright © 1982 by Endocrine Society


ARTICLES

Binding of 3H-Sertoli cell factor to rat anterior pituitary in vitro

A Steinberger, L Seethalakshmi, M Kessler and E Steinberger

The binding characteristics of Sertoli Cell Factor (SCF) to the anterior pituitaries were examined using tissue homogenates and cultured cells. Tritium-labeled SCF (3H-SCF), synthesized by rat Sertoli cells in vitro in the presence of 3H-leucine and partly purified by Sephadex gel chromatography, was used to the ligand. The binding of 3H-SCF to the pituitary homogenates or cultured cells was considerably greater (3-6X) compared to homogenates of brain, kidney, liver, spleen and testis. The pituitary binding at 37 C occurred after approximately 60 time dependent, and directly related to the receptor concentration. Maximum binding at 37 C occurred after approximately 60 min of incubation. Over 90% of the bound 3H-SCF was competitively inhibited by an excess of unlabeled SCF, but not by other substances. There was a good correlation between the binding of 3H-SCF and its biological activity, as evidenced by a selective suppression of basal FSH release in pituitary cell cultures. These data indicate that, in analogy to other protein hormones, specific binding to target cell receptors may represent an initial step of SCF action in the pituitary. The binding should also prove valuable in the development of a rapid radio-receptor assay for SCF and possibly for other inhibin preparations.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1982 by The Endocrine Society